Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support
Hypernatremia: Reflects a deficit of water compared with total body sodium. Therapy should be
adjusted to achieve a serum sodium concentration decrease of 6β8 mEq/L per day; no faster than 10β12
mEq/L per day to reduce the risk of cerebral edema.
Evaluation
Evaluate ECF volume status (increased, normal, decreased). Increased ECF volume is
caused by excessive sodium intake (oral salt tablets, hypertonic saline, 0.9% sodium chloride
solution, lactated Ringer solution, PlasmaLyte/Normosol). This is the least common cause of
hypernatremia. Decreased ECF (hypovolemia, dehydration) results from excessive losses of
both water and sodium.
ii.
Consider urine sodium together with volume status to determine cause and treatment.
Treatment
Hypervolemic hypernatremia β Treated with diuretics, sodium restriction, water replacement,
and/or renal replacement therapy
ii.
Euvolemic hypernatremia β Treated with free water replacement
| (a) | For normal or increased ECF volume, estimate free water deficit with the Adrogue-Madias |
|---|
equation (N Engl J Med 2000;342:1493-9): 0.6 x Wt (kg) x [(serum sodium/140) β 1] (use
0.5 x Wt (kg) for women). Correct deficit over 2β3 days. The equation often underestimates
2013;87:79-85). This is typically accomplished using enteral free water boluses (e.g.,
200β300 mL every 4β6 hours) if the patient has a nasogastric feeding or suction tube.
Administration of high volumes of enteral water boluses should be avoided if the patient
has a post-pyloric tube because it causes cramping and diarrhea. Rare cases of bowel
necrosis postβlarge water boluses have also occurred when administered directly into the
small bowel (J Parenter Enteral Nutr 2004;28:27-9). If the enteral route is not possible
or the patient is intolerant of enteral water boluses, intravenous dextrose 5% in water or
dextrose 5% in 0.225% sodium chloride can be used.
| (b) | The anticipated change in serum sodium concentration after 1 L of any intravenous fluid |
|---|
can be estimated as follows: [sodium concentration of IV fluid (mEq/L) β serum sodium
concentration (mEq/L)] / [TBW + 1] (N Engl J Med 2000;342:1493-9). Refer to Table 5 for
sodium concentration of commonly used intravenous fluids.
iii.
Hypovolemic hypernatremia β Initially treated with volume expansion to restore hemodynamic
stability because total body sodium and volume is low. If hypernatremia is still present once
the patient is hemodynamically stable, free water replacement can be initiated as stated earlier.
iv.
Clinical evaluation during volume repletion is of paramount importance. Serum sodium
should be checked routinely (e.g., every 6β12 hours) to avoid overcorrection. All sources of
excess fluid losses should be monitored and replaced with the appropriate fluid, if indicated.
ECF Volume Status
Hypervolemic
Euvolemic
Hypovolemic
Physiologic findings
See Table 6
Urine sodium (mEq/L)
> 20
Varies
< 20
> 20
Potential etiologies
Excessive sodium
intake from intravenous
or oral, mineralocorti-
coid excess
Extrarenal losses
(insensible losses),
Renal losses
(diabetes insipidus)
Extrarenal
losses (fever,
diarrhea,
respiratory
losses)
Renal losses
(diuretics,
glycosuria,
kidney failure/
injury), diabetic
ketoacidosis,
hyperosmolar
hyperglycemic
syndrome